Alnylam Pharmaceuticals
ALNY
#618
Rank
NZ$54.51 B
Marketcap
$421.20
Share price
-10.08%
Change (1 day)
67.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company